<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Characteristics of sexually transmitted genital ulcers</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Characteristics of sexually transmitted genital ulcers</h1>
<div class="graphic"><div class="figure"><div class="ttl">Characteristics of sexually transmitted genital ulcers</div><div class="cntnt"><table cellspacing="0"><colgroup span="6" width="16.66%"></colgroup> <tbody> <tr> <td class="subtitle1">Â </td> <td class="subtitle1">Primary syphilis</td> <td class="subtitle1">Genital herpes</td> <td class="subtitle1">Chancroid</td> <td class="subtitle1">Lymphogranuloma venereum</td> <td class="subtitle1">Donovanosis</td> </tr> <tr> <td><strong>Etiology</strong></td> <td><em>Treponema pallidum</em>.</td> <td>Herpes simplex.</td> <td><em>Haemophilus ducreyi</em>.</td> <td><em>Chlamydia trachomatis</em>.</td> <td><em>Klebsiella granulomatis</em>.</td> </tr> <tr> <td><strong>Incubation period</strong></td> <td>9 to 90 days; average 2 to 4 weeks.</td> <td>2 to 7 days.</td> <td>1 to 35 days; average 3 to 7 days.</td> <td>3 days to 3 weeks; average 10 to 14 days.</td> <td>Precise data unavailable; probably a few days to several months.</td> </tr> <tr> <td><strong>Number of lesions</strong></td> <td>Usually single lesion, but multiple lesions may occur.</td> <td>Multiple; may coalesce; more lesions appear in primary episodes than in recurrences.</td> <td>Usually 1 to 3, but multiple lesions may occur.</td> <td>Usually single.</td> <td>Single or multiple.</td> </tr> <tr> <td><strong>Appearance of genital ulcers</strong></td> <td>Sharply demarcated round or oval ulcer with slightly elevated edges; may be irregular or symmetrical ("kissing chancre").</td> <td>Small superficial grouped vesicles and/or erosions; lesions may coalesce, forming bullae or large areas of ulceration; lesions have irregular borders.</td> <td>Deep, sharply demarcated ulcer; irregular ragged undermined edge; ranges in diameter from a few mm to 2 cm.</td> <td>Papule, pustule, vesicle, or ulcer; discrete and transient; frequently overlooked.</td> <td>Sharply defined irregular ulcerations or hypertrophic, verrucous, necrotic, or cicatricial granulomas.</td> </tr> <tr> <td><strong>Base</strong></td> <td>Red, smooth and shiny, or crusted; serous exudate occurs when squeezed.</td> <td>Bright, red, and smooth.</td> <td>Rough, uneven, yellow to gray in color.</td> <td>Variable.</td> <td>Usually friable, rough, beefy granulations; can be necrotic, verrucous, or cicatricial.</td> </tr> <tr> <td><strong>Induration</strong></td> <td>Firm; does not change shape with pressure.</td> <td>None.</td> <td>Soft; changes shape with pressure.</td> <td>None.</td> <td>Firm granulation tissue.</td> </tr> <tr> <td><strong>Pain</strong></td> <td>Painless; may become tender if secondarily infected.</td> <td>Common; more prominent with initial infection than with recurrences.</td> <td>Common.</td> <td>Variable.</td> <td>Rare.</td> </tr> <tr> <td><strong>Inguinal lymphadenopathy</strong></td> <td>Unilateral or bilateral; firm, movable, and nontender; do not suppurate.</td> <td>Usually bilateral, firm, and tender; more common in primary episodes than in recurrences.</td> <td>Unilateral (rarely bilateral); overlying erythema; matted, fixed, and tender; may suppurate.</td> <td>Unilateral or bilateral; initially movable, firm, and tender; later indolent; fixed and matted; "sign of Groove" may suppurate; fistulas.</td> <td>Pseudobuboes; subcutaneous perilymphatic granulomatous lesions that produce inguinal swelling.</td> </tr> <tr> <td><strong>Constitutional symptoms</strong></td> <td>Rare.</td> <td>Common in primary episode; less likely in recurrences.</td> <td>Rare.</td> <td>Frequent.</td> <td>Rare.</td> </tr> <tr> <td><strong>Course of disease if untreated</strong></td> <td>Slowly resolves to latency (2 to 6 weeks).</td> <td>Typically recurs.</td> <td>May progress to erosive lesions.</td> <td>Local lesions heal; systemic disease may progress; disfigurement; late complications.</td> <td>Worsens slowly.</td> </tr> <tr> <td><strong>Diagnostic tests</strong></td> <td>Darkfield exam, direct immunofluorescence, FTA-ABS, VDRL, RPR.</td> <td>Culture, PCR, direct immunofluorescence, serology, Tzanck smear, Pap smear, electron-microscopy, direct immunoperoxidase staining.</td> <td>Culture, biopsy (rarely done); Gram stained smears have low specificity.</td> <td>LGV complement fixation test; isolation of the microorganism by culture.</td> <td>"Donovan bodies" in tissue smears; biopsy.</td> </tr> </tbody></table></div><div class="graphic_footnotes">FTA-ABS: fluorescent treponemal antibody absorption; VDRL: Venereal Disease Research Laboratory; RPR: rapid plasma reagin; PCR: polymerase chain reaction; LGV: lymphogranuloma venereum.</div><div class="graphic_reference">Adapted with permission from: Martin DH, Mroczkowski TF. Sexually transmitted diseases. In: The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT (Eds), Williams &amp; Wilkins, Baltimore 1995. p.95.</div><div id="graphicVersion">Graphic 60432 Version 5.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
